Exact Mass: 618.3404

Exact Mass Matches: 618.3404

Found 25 metabolites which its exact mass value is equals to given mass value 618.3404, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Minosaminomycin

(2S)-2-[[(2S)-3-[(4R)-2-amino-4,5-dihydro-1H-imidazol-4-yl]-1-[[(2S,3S,5R,6S)-4-[(2R,3S,5S,6R)-3,5-diamino-6-methyloxan-2-yl]oxy-2,3,5,6-tetrahydroxycyclohexyl]amino]-1-oxopropan-2-yl]carbamoylamino]-4-methylpentanoic acid

C25H46N8O10 (618.3337)

(E)-(S)-4-[(S)-4-Methyl-2-((S)-3-methyl-2{(S)-2-[(5-methyl-isoxazole-3-carbonyl)-amino]-propionylamino}-butyrylamino)-pentanoylamino]-5-((S)-2-oxo-pyrrolidin-3-YL)-pent-2-enoic acid ethyl ester

C30H46N6O8 (618.3377)

2-[[(2R)-3-acetyloxy-2-[(5R,6Z,8E,10E,12S,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO10P+ (618.3407)

2-[[(2R)-2-acetyloxy-3-[(5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxyicosa-6,8,10,14-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO10P+ (618.3407)

2-[[(2R)-3-acetyloxy-2-[(5S,6E,8Z,11Z,13E,15R)-5,15-dihydroxyicosa-6,8,11,13-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO10P+ (618.3407)

2-[[(2R)-2-acetyloxy-3-[(5R,6E,8Z,11Z,13E,15S)-5,15-dihydroxyicosa-6,8,11,13-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO10P+ (618.3407)

2-[[(2R)-3-acetyloxy-2-[(5R,6R,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO10P+ (618.3407)

2-[[(2R)-2-acetyloxy-3-[(5S,6S,8Z,11Z,14Z,17Z)-5,6-dihydroxyicosa-8,11,14,17-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C30H53NO10P+ (618.3407)

2-(3-((Z)-3-Tributylstannyl-1-propenoxy)-(2R,3S,5AR,6AS,10AR,12AS)-tetrahydropyrano(3,2-B)oxepano(2,3:6,7)oxepan-2-YL)ethanal

C30H58O5Sn (618.3306)

[1-[(6E,9E,12E)-pentadeca-6,9,12-trienoyl]oxy-3-phosphonooxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate

C34H51O8P (618.3321)

(2S)-2-[[(2S)-3-[(4R)-2-amino-4,5-dihydro-1H-imidazol-4-yl]-1-[[(2S,3S,5R,6S)-4-[(2R,3S,5S,6R)-3,5-diamino-6-methyloxan-2-yl]oxy-2,3,5,6-tetrahydroxycyclohexyl]amino]-1-oxopropan-2-yl]carbamoylamino]-4-methylpentanoic acid

C25H46N8O10 (618.3337)

MGGA 25:7

C34H50O10 (618.3404)

PEth 29:8

C34H51O8P (618.3321)

PM 30:8

C34H51O8P (618.3321)

ST 28:4;O4;GlcA

C34H50O10 (618.3404)

ST 28:5;O5;Hex

C34H50O10 (618.3404)

2-({[1-({4-[(3,5-diamino-6-methyloxan-2-yl)oxy]-2,3,5,6-tetrahydroxycyclohexyl}-c-hydroxycarbonimidoyl)-2-(2-iminoimidazolidin-4-yl)ethyl]-c-hydroxycarbonimidoyl}amino)-4-methylpentanoic acid

C25H46N8O10 (618.3337)

(2r)-2-({[(1r)-1-{[(2r,3r,5s,6s)-4-{[(2s,3s,5s,6r)-3,5-diamino-6-methyloxan-2-yl]oxy}-2,3,5,6-tetrahydroxycyclohexyl]-c-hydroxycarbonimidoyl}-2-[(4s)-2-iminoimidazolidin-4-yl]ethyl]-c-hydroxycarbonimidoyl}amino)-4-methylpentanoic acid

(2r)-2-({[(1r)-1-{[(2r,3r,5s,6s)-4-{[(2s,3s,5s,6r)-3,5-diamino-6-methyloxan-2-yl]oxy}-2,3,5,6-tetrahydroxycyclohexyl]-c-hydroxycarbonimidoyl}-2-[(4s)-2-iminoimidazolidin-4-yl]ethyl]-c-hydroxycarbonimidoyl}amino)-4-methylpentanoic acid

C25H46N8O10 (618.3337)

(1s,3as,3bs,9ar,9bs,11as)-1-[(1r)-1-[(1r,2r,4r,6s)-1,6-dimethyl-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,7-dioxabicyclo[4.1.0]heptan-4-yl]ethyl]-1-hydroxy-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-9-one

(1s,3as,3bs,9ar,9bs,11as)-1-[(1r)-1-[(1r,2r,4r,6s)-1,6-dimethyl-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,7-dioxabicyclo[4.1.0]heptan-4-yl]ethyl]-1-hydroxy-9a,11a-dimethyl-2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-9-one

C34H50O10 (618.3404)

methyl 2-[(1z,2s,3as,3bs,4r,5r,6s,7r,9as,11r)-2,5-bis(acetyloxy)-4,7,11-trihydroxy-3a,3b,6,9a-tetramethyl-10-oxo-dodecahydrocyclopenta[a]phenanthren-1-ylidene]-6-methylhept-5-enoate

C34H50O10 (618.3404)